Peripapillary Pachychoroid Syndrome

Peripapillary Pachychoroid Syndrome is an eye condition. It sits inside the “pachychoroid” family of disorders. “Pachy” means thick. “Choroid” is the blood-vessel layer under the retina. In PPS, the choroid is abnormally thick and its large vessels are dilated near the optic nerve head (the “peripapillary” area). This crowding and extra pressure can make fluid leak into the retina. The fluid collects first around the optic nerve and the nasal side of the macula. This can blur vision and warp shapes. Doctors can see the thick choroid and the fluid on modern scans. PPS is most often found in older, usually farsighted eyes with short axial length and sometimes in eyes with a crowded optic disc. PubMed+1

Peripapillary Pachychoroid Syndrome is a newer member of the “pachychoroid” family of eye conditions. “Pachy-” means thick; “choroid” is the blood-vessel layer under the retina. In PPS, that choroid is abnormally thick around the optic nerve (the disc), and the large choroidal vessels are dilated and leaky. This extra pressure and fluid can seep into the retina near the disc, forming intraretinal cysts and sometimes a small pocket of subretinal fluid that can creep toward the center of vision. Unlike classic central serous chorioretinopathy (CSC), fluid in PPS often starts at the edge of the optic disc and tracks toward the macula, and intraretinal cysts are a hallmark clue in many patients. Some eyes also show mild optic disc swelling and peripapillary retinal pigment epithelium (RPE) atrophy. Nature+1EyeWiki+1

Think of the choroid as a sponge full of blood vessels. In PPS, the deep, large choroidal veins (called pachyvessels) are bigger than normal. Blood does not drain smoothly. Pressure in the choroid rises. This pressure pushes up on the thin support layers under the retina (Bruch’s membrane and the retinal pigment epithelium, or RPE). The RPE struggles to pump fluid back. Small amounts of fluid seep into and under the retina near the optic nerve. Over time, this fluid can spread toward the central retina. Modern research suggests that venous congestion and even scleral (white of the eye) thickness or outflow resistance may be part of the story, which fits with the tendency for shorter, more hyperopic (farsighted) eyes. Nature

Who tends to get PPS?

• People in their 70s are common in published series.

• Men are affected more often than women in early reports.

• Farsighted eyes and short axial length (<23 mm) show up frequently.

• The optic disc can look “crowded,” and choroidal folds may be present.
  These features come from the largest early description of PPS and have been seen again in later reports. PubMed

---

Types

There is no single official “staging” used everywhere. But in daily practice, doctors often recognize patterns. These patterns are useful because they predict what patients feel and what scans show.

1. Peripapillary-only fluid
   Fluid sits around the optic nerve. The macula may still be dry. Vision can be near normal, but patients may notice subtle distortion or a smudge near the nasal field.

2. Peripapillary fluid with macular extension
   Fluid creeps from the optic nerve area into the macula. Blurred central vision and waviness of lines become more obvious.

3. PPS with optic disc edema
   The disc can look mildly swollen. This can confuse the picture and mimic inflammatory or neurologic disease. Careful imaging helps tell them apart. PubMed

4. PPS with choroidal neovascularization (CNV)
   New, abnormal vessels can grow under the retina. This is less common but important because it can cause bleeding or more fluid. Optical coherence tomography angiography (OCT-A) helps detect these new vessels.

5. Chronic or recurrent PPS
   Fluid and RPE changes persist or return over months or years. The retina may thin in spots. Vision may fluctuate.

Note: These patterns are descriptive, not rigid categories. The same eye can move from one pattern to another over time.

---

Causes and Risk Factors

The exact cause of PPS is not fully known. But research and clinical experience point to mechanisms and contexts that make PPS more likely. Below are 20 contributors, grouped and explained in simple terms. When a point is strongly supported for PPS itself, I say so. When it is inferred from the broader pachychoroid literature (like central serous chorioretinopathy, CSC), I say that too.

1. Thick choroid with dilated deep veins (pachyvessels) — This is the core feature of PPS and likely the main driver of fluid. The big choroidal veins crowd the tissue and raise pressure. Nature

2. Choroidal venous congestion — Blood outflow is sluggish. Pressure rises and pushes fluid toward the retina. Nature

3. Farsighted eyes (hyperopia) — PPS cohorts show a high rate of hyperopia. The eye is shorter, and anatomy may favor congestion. PubMed

4. Short axial length (<23 mm) — Shorter eyes are reported often in PPS. PubMed

5. Crowded optic disc anatomy — The disc can look tight or crowded, which may relate to local fluid behavior. PubMed

6. Older age — PPS is reported mostly in older adults (often 60s–70s). PubMed

7. Male sex — Early series show a male predominance (about 80% men). Lippincott Journals

8. Choroidal folds — Folds reflect mechanical stress in the choroid and are common in PPS. PubMed

9. Thicker or stiffer sclera (inferred) — A thicker or less “drainable” sclera may raise venous pressure in the choroid, based on pachychoroid research. Nature

10. Global pachychoroid phenotype — People with other pachychoroid conditions (like CSC or PPE) can also show peripapillary involvement. PMC

11. Systemic steroid exposure (inferred from pachychoroid/CSC) — Steroids can worsen fluid in CSC and related conditions; PPS may share this sensitivity. Evidence for PPS is limited, so this is a cautious inference. Nature

12. High sympathetic tone / stress hormones (inferred) — Stress links to CSC; PPS may share some pathways, though direct PPS evidence is modest. Nature

13. Obstructive sleep apnea (inferred) — Sleep apnea associates with CSC; PPS overlap is plausible but not as well proven. Nature

14. Systemic hypertension (inferred) — Vascular stress may worsen choroidal congestion. Evidence is stronger in pachychoroid generally than in PPS alone. Nature

15. Caffeine/adrenergic drugs (inferred) — Agents that constrict or alter vascular tone can aggravate pachychoroid fluid in some patients. Evidence in PPS is anecdotal. Nature

16. Testosterone or anabolic steroids (inferred) — Linked with CSC; PPS may share susceptibility. Nature

17. Pregnancy (rare, inferred) — CSC can occur in pregnancy; PPS is usually in older adults, so this is theoretically possible but rare. Nature

18. Thyroid eye disease / raised episcleral venous pressure (inferred) — Conditions that raise venous pressure may worsen choroidal congestion.

19. Valsalva-type strain (inferred) — Brief venous spikes may worsen transient fluid in susceptible eyes.

20. Genetic/structural predisposition (hypothesized) — The anatomic pattern of vortex veins and sclera may set the stage for some people. Nature

---

Symptoms

1. Blurred central or near-central vision — Objects look softer or cloudy.

2. Wavy lines (metamorphopsia) — Straight lines look bent, especially on reading.

3. A gray or smudged spot near the nose side of the central vision.

4. Patchy or paracentral missing area (scotoma) — A small blind patch or “hole.”

5. Shape or size distortion (micropsia) — Things can look slightly smaller.

6. Color looks washed out in the affected area.

7. Trouble reading small print — Letters swim or shimmer.

8. Glare and light sensitivity — Light scatters more through fluid.

9. Fluctuating vision — Vision gets better or worse over days to weeks.

10. Headache from eye strain — The eye works harder to focus.

11. Mild hyperopic shift — Glasses prescription may change toward farsightedness when fluid is present.

12. Difficulty with low-contrast tasks — Faces or signs are harder to see in dim light.

13. Depth perception feels off — Straight edges and steps can look odd.

14. Rarely, transient dimming if the disc is swollen, which can mimic nerve problems. PubMed

15. Usually no pain and no redness — The eye looks normal on the outside.

---

Diagnostic Tests

Below are 20 tests, spread across five groups. Each one is written in plain English so you know what it is and why it helps.

A) Physical Exam

1. Best-corrected visual acuity (BCVA)
   You read letters on a chart with the best lenses in place. This measures how much the fluid has blurred your vision.

2. Refraction (often with cycloplegia)
   The doctor checks your glasses power carefully. PPS eyes often are farsighted and shorter than average; careful refraction also shows if fluid causes a temporary hyperopic shift. PubMed

3. Pupil exam with swinging flashlight test
   This looks for an afferent pupillary defect. PPS itself does not usually damage the optic nerve, but the test helps rule out nerve disease if the disc looks swollen.

4. Confrontation visual fields at the slit lamp
   You count fingers or detect moving targets. It screens for missing patches in your field while you wait for formal imaging.

B) Manual / Bedside Clinical Tests

5. Amsler grid
   You look at a small checkerboard. Wavy or missing lines show metamorphopsia or scotoma from macular fluid.

6. Dilated fundus exam with a 90D/78D lens
   The clinician looks directly at your retina. In PPS, they may see peripapillary serous detachment, RPE changes, or choroidal folds.

7. Indirect ophthalmoscopy (with scleral depression if needed)
   This panoramic exam checks the far periphery. It helps rule out other causes of subretinal fluid and confirms the peripapillary focus.

C) Laboratory / Pathological Tests

Lab tests do not diagnose PPS by themselves. They help exclude look-alikes like inflammatory or infectious disease that can produce serous detachment or disc swelling.

8. ESR and CRP
   These are inflammation markers. High levels may push the doctor to look for inflammatory uveitis or systemic vasculitis instead of PPS.

9. Syphilis serology (non-treponemal + treponemal tests)
   Syphilis can mimic many eye diseases, including peripapillary fluid and disc leakage. A negative test supports PPS after imaging.

10. TB screening (IGRA) and, if indicated, ACE/lysozyme
    These help screen for sarcoidosis or tuberculosis-related inflammation, conditions that can mimic PPS in the peripapillary area.

11. Autoimmune screen (e.g., ANA)
    If the history suggests an autoimmune disease, this helps rule it in or out when peripapillary inflammation is a concern.

D) Electrodiagnostic Tests

These tests study how the retina and visual pathway work. PPS often has normal or near-normal results if damage is mild, but the tests are useful when the picture is confusing.

12. Multifocal ERG (mfERG)
    Maps function across the macula. It can show reduced signals where the fluid sits.

13. Full-field ERG
    Measures overall retinal function. It is usually normal in PPS, which helps distinguish it from diffuse retinal diseases.

14. Pattern ERG (pERG)
    Focuses on ganglion cell function. It helps if you worry about optic nerve disease from true disc swelling.

15. Visual Evoked Potential (VEP)
    Checks the visual pathway from eye to brain. A normal VEP with imaging signs of PPS supports a retinal fluid problem rather than optic neuropathy.

E) Imaging Tests

These are the key tests. PPS is a multimodal imaging diagnosis.

16. Optical Coherence Tomography (OCT) with Enhanced-Depth or Swept-Source
    This is the cornerstone. OCT shows peripapillary intraretinal or subretinal fluid, serous RPE detachments, and thick choroid with dilated deep vessels, often nasal to the fovea and around the disc. It also shows choroidal folds. PubMed

17. OCT Angiography (OCT-A)
    OCT-A maps blood flow without dye. It helps detect choroidal neovascularization (CNV) if vision drops or fluid behaves atypically.

18. Fluorescein Angiography (FA)
    FA often shows peripapillary RPE mottling and sometimes mild late disc leakage, but it usually lacks the strong focal leaks seen in classic CSC. This pattern supports PPS and helps rule out inflammation. Lippincott Journals

19. Indocyanine Green Angiography (ICGA)
    ICGA highlights the choroid. PPS often shows dilated peripapillary pachyvessels and choroidal hyperpermeability, which fit the venous congestion story. PubMed

20. Fundus Autofluorescence (FAF)
    FAF maps lipofuscin at the RPE. In PPS you can see peripapillary mottling or tracks that match chronic fluid movement and RPE stress. Lippincott Journals

Non-Pharmacological Treatments (therapies & other measures)

1) Careful observation with scheduled OCT follow-up
Purpose: avoid overtreatment; many eyes stabilize.
Mechanism: lets natural fluid cycling settle while protecting the fovea through monitoring. bjo.bmj.com

2) Minimize or stop corticosteroids where medically safe (including creams, inhalers, nasal sprays).
Purpose: remove a strong pachychoroid/CSC trigger.
Mechanism: lower cortisol/mR pathway stimulation that can worsen choroidal leakage. Coordinate with your non-eye doctors before changing any meds. ScienceDirect

3) Screen and treat Obstructive Sleep Apnea (OSA)
Purpose: reduce nocturnal hypoxia/catecholamine surges that may aggravate choroidal pressure.
Mechanism: CPAP normalizes oxygen and autonomic tone, which may reduce relapse risk. Ajo

4) Stress reduction (CBT, mindfulness, breathing drills, yoga, short walks)
Purpose: tame cortisol/adrenaline spikes linked to CSC-like activity.
Mechanism: lowers sympathetic drive that can affect choroidal perfusion. ScienceDirect

5) Sleep hygiene (regular sleep window, dark/cool room, limit screens late).
Purpose: stabilize autonomic balance and cortisol rhythm.
Mechanism: reduces physiologic stress that may worsen fluid shifts. ScienceDirect

6) Review “trigger” medicines with your doctors (decongestants, stimulants).
Purpose: reduce sympathetic vasoconstriction and choroidal stress.
Mechanism: fewer adrenaline-like surges. ScienceDirect

7) Blood pressure control & cardiovascular risk management
Purpose: support healthier choroidal circulation.
Mechanism: steadier perfusion pressure to the choroid.

8) Smoking cessation
Purpose: improve microvascular health.

9) Moderate caffeine/energy drinks
Purpose: avoid spikes in sympathetic tone. ScienceDirect

10) Limit alcohol, especially late
Purpose: improves sleep quality; reduces OSA and cortisol disruption. Ajo

11) Ergonomic lighting & contrast aids for reading
Purpose: reduce strain while fluid resolves.
Mechanism: better contrast and font size compensate for local blur.

12) Amsler grid at home once weekly
Purpose: early warning if fluid reaches the center.
Mechanism: detects new distortion fast so treatment isn’t delayed.

13) Protect from intense glare / use quality sunglasses
Purpose: comfort if macula is irritable.

14) Balanced hydration & moderate salt intake
Purpose: avoid fluid retention extremes (indirect support).

15) Weight management
Purpose: lowers OSA risk and improves BP.

16) Treat reflux if present
Purpose: better sleep; less nocturnal arousal.

17) Schedule breaks for near work
Purpose: reduce subjective strain while recovering.

18) Keep a symptom diary
Purpose: track triggers (stress, poor sleep, colds + decongestants).

19) Educate family/primary-care team about steroid sensitivity
Purpose: prevents accidental re-exposure.

20) Prompt follow-up if vision changes
Purpose: catch foveal involvement early for timely therapy.

---

Drug Treatments

Important: No drug is formally approved specifically for PPS. Choices below come from pachychoroid/CSC evidence, PPS cohorts, and case reports. Your retina specialist will tailor and monitor these carefully.

1) Verteporfin (for Photodynamic Therapy, PDT)
Class: Photosensitizer (procedure-based).
Typical dose/timing: IV verteporfin ~6 mg/m²; half-dose or half-fluence PDT is often used in pachychoroid diseases; parameters individualized.
Purpose: reduce choroidal hyperpermeability and fluid.
Mechanism: light-activated verteporfin remodels abnormal choroidal vessels, reducing leakage.
Side effects: transient vision changes, rare choroidal ischemia; light-sensitivity precautions after infusion. In PPS, a multicenter pilot showed meaningful anatomical/visual improvement in many eyes. DOI

2) Aflibercept (anti-VEGF) intravitreal injection
Class: Anti-VEGF biologic.
Dose/timing: 2 mg injection; schedule varies (e.g., monthly loading then q8 weeks).
Purpose: treat CNV if present; may help fluid even without obvious CNV in select cases.
Mechanism: neutralizes VEGF, reduces permeability and neovascular activity.
Side effects: rare infection, pressure rise, transient floaters. Case report shows benefit in PPS. Lippincott Journals

3) Ranibizumab (anti-VEGF) intravitreal injection
Dose/timing: 0.5 mg; monthly then individualized.
Purpose/mechanism/risks: as above; responses vary; often used if CNV is proven. Lippincott Journals

4) Dorzolamide 2% (topical CAI)
Class: Carbonic anhydrase inhibitor (drop).
Dose/timing: 1 drop 2–3×/day.
Purpose: help absorb intraretinal/subretinal fluid faster (evidence stronger in CSC than PPS).
Mechanism: boosts fluid pumping through the RPE.
Side effects: burning, bitter taste, rare corneal effects. BioMed Central

5) Brinzolamide 1% (topical CAI)
Dose/timing: 1 drop 2–3×/day.
Purpose/mechanism/risks: similar to dorzolamide; sometimes tried if dorzolamide is not tolerated. BioMed Central

6) Acetazolamide (oral CAI)
Dose/timing: 125–250 mg 1–3×/day for short courses (days to a couple weeks), if used.
Purpose: speed fluid re-absorption in some serous maculopathies; used selectively given side-effects.
Mechanism: enhances RPE pumping via CAI effects.
Side effects: tingling, fatigue, metallic taste, kidney stones; caution in sulfa allergy; adjust for kidney function. AAO

7) Eplerenone (mineralocorticoid receptor antagonist, oral)
Dose/timing: 25–50 mg/day with potassium/renal monitoring.
Purpose: targets mineralocorticoid pathway implicated in CSC; high-quality RCT in chronic CSC showed no superiority to placebo, so routine use is controversial; may be considered case-by-case.
Side effects: high potassium, low BP, dizziness. ScienceDirect

8) Spironolactone (oral)
Dose/timing: 25–50 mg/day with monitoring (and contraception if pregnancy-capable).
Purpose/mechanism: like eplerenone; evidence mixed and largely from CSC case series.
Side effects: high potassium, breast tenderness, menstrual changes. PubMed

9) Prednisolone acetate 1% (topical steroid) — use is controversial
Dose/timing: Case reports used 3×/day then slow taper over months.
Purpose: reported to reduce fluid in selected PPS cases; however, experts caution that steroids are a major risk factor in pachychoroid/CSC and may worsen disease; any use should be highly selective and closely monitored by a retina specialist.
Side effects: eye pressure rise, cataract over long term, infection risk. PMCNature

10) (If CNV develops) Combination therapy
Approach: anti-VEGF ± PDT where CNV complicates PPS, tailored to imaging.
Rationale: treats both vascular leak (PDT) and neovascular drive (anti-VEGF). DOI

---

Dietary “Molecular” Supplements

There is no supplement proven to cure PPS. These options support general retinal and vascular health and are sometimes used in broader macular care. Discuss with your doctor, especially if you take multiple medicines.

1. AREDS2 blend (vit C 500 mg, vit E 400 IU, zinc 80 mg as zinc oxide, copper 2 mg, lutein 10 mg, zeaxanthin 2 mg daily): eye-health antioxidant/carotenoid support (evidence is for AMD, not PPS).

2. Lutein 10 mg + Zeaxanthin 2 mg (if not using AREDS2): macular pigment support.

3. Omega-3 (EPA/DHA ~1 g/day): general anti-inflammatory/vascular support (hold before surgery per surgeon advice).

4. Saffron 20–30 mg/day: small AMD studies suggest visual function benefits; unproven in PPS.

5. CoQ10 100–200 mg/day: mitochondrial support; limited ocular data.

6. Vitamin D 1000–2000 IU/day if deficient: systemic health/immune modulation.

7. Magnesium 200–400 mg/day: relaxes smooth muscle/vascular tone; check kidneys.

8. Anthocyanins (bilberry/blackcurrant extracts as labeled): antioxidant support.

9. Curcumin 500–1000 mg/day with piperine: systemic anti-inflammatory; check drug interactions.

10. N-acetylcysteine 600–1200 mg/day: antioxidant; may thin mucus—discuss with clinician.

These are supportive, not disease-specific therapies; use only with medical guidance.

---

Regenerative or stem-cell drugs

There are no approved immune-booster drugs, regenerative drugs, or stem-cell therapies for PPS. Unapproved stem-cell injections into the eye have blinded patients. U.S. FDA and major eye societies warn strongly against clinics selling such treatments outside regulated trials. Please avoid them. If you’re curious about clinical research, your retina specialist can help verify legitimate, regulated trials. U.S. Food and Drug AdministrationNew England Journal of MedicineAAO

---

Procedures /surgeries

1. Photodynamic Therapy (PDT) with verteporfin
   Why: best-supported option within the pachychoroid spectrum to shrink choroidal leakiness and dry fluid, including in PPS. Often used with half-dose/half-fluence settings to balance benefit and safety. DOI

2. Intravitreal anti-VEGF injections (aflibercept/ranibizumab)
   Why: mandatory if CNV forms; may be tried in select PPS without proven CNV when fluid persists and PDT isn’t suitable. Lippincott Journals

3. Combined therapy (PDT + anti-VEGF)
   Why: addresses both choroidal hyperpermeability and neovascular drive when both are present. DOI

4. Subthreshold micropulse laser (rare, case-by-case)
   Why: sometimes considered when PDT is unavailable/unsuitable; evidence in CSC is mixed and generally weaker than PDT. DOI

5. Conservative care as a “procedure plan”
   Why: structured observation with rapid access to treat if the fovea becomes involved or fluid persists beyond a reasonable window.

Traditional incisional surgeries are not part of PPS care.

---

Prevention Tips

1. Avoid steroids if alternatives exist (confirm with your other doctors). ScienceDirect

2. Treat OSA (CPAP if prescribed). Ajo

3. Manage stress (daily 10–15 minutes of calm practice). ScienceDirect

4. Regular sleep schedule (aim 7–8 hours).

5. Control blood pressure and general heart health.

6. Stop smoking; avoid vaping/nicotine.

7. Moderate caffeine/energy drinks. ScienceDirect

8. Limit alcohol, especially late evening.

9. Double-check all meds for hidden steroids/sympathomimetics.

10. Keep follow-ups and test promptly if you notice new distortion.

---

When to see a doctor urgently

• New or worsening distortion, a dark spot, or sudden blur—especially if it reaches the center of vision.

• Any change after starting a steroid medication. ScienceDirect

• Persistent symptoms beyond a few weeks despite rest and risk-factor control.

• New floaters/flashes or a curtain in vision (emergent, to rule out other problems).

• If you have OSA symptoms (snoring, daytime sleepiness)—ask for evaluation. Ajo

---

What to eat and what to avoid

Eat more of:

1. Leafy greens (spinach, kale) for lutein/zeaxanthin.

2. Colorful vegetables and fruits (peppers, oranges, berries) for antioxidants.

3. Fatty fish (salmon, sardines) 2×/week for omega-3s.

4. Nuts and seeds (almonds, walnuts, flax) for healthy fats and vitamin E.

5. Whole grains/legumes for stable energy and vascular health.

Limit/avoid:

1. High-sodium ultra-processed foods (chips, instant noodles) that can worsen BP.
2. Energy drinks and excess caffeine, which can push sympathetic tone. ScienceDirect
3. Heavy late-night meals (sleep disruption/OSA). Ajo
4. Excess alcohol (hurts sleep, raises BP).
5. Smoking/vaping (not food, but crucial for vessel health).

Diet supports overall ocular health but does not replace medical care for PPS.

---

Frequently Asked Questions

1) Is PPS the same as CSC?
No. They are related pachychoroid conditions, but PPS typically has intraretinal cysts that start at the disc edge and move toward the macula, with thick choroid around the disc; CSC usually shows subretinal fluid from macular leakage without peripapillary-origin cysts. Nature

2) Can PPS get better on its own?
Yes—many eyes improve or stabilize over time, especially if the fovea isn’t involved. That’s why observation is often reasonable at first. bjo.bmj.com

3) What is the best proven treatment?
For persistent or center-involving cases without CNV, PDT has the most consistent evidence in the pachychoroid spectrum and showed benefit in PPS in a pilot study. DOI

4) Are steroid eye drops a good idea?
Generally no in pachychoroid conditions; steroids are a known CSC trigger. While a few PPS case reports describe improvement with topical steroids, experts advise caution and prefer PDT for selected cases. Nature

5) Do anti-VEGF injections help?
They are essential if CNV is present. Some case-level evidence suggests aflibercept may help in PPS without obvious CNV, but it’s not established as standard for all PPS. Lippincott Journals

6) Will I go blind?
Most patients do not, especially with monitoring and timely care. However, untreated foveal fluid can blur central vision—so don’t delay evaluation if symptoms reach the center. bjo.bmj.com

7) Can glasses fix PPS?
Glasses correct refractive error, not retinal fluid. You still need retinal evaluation and treatment decisions.

8) Does screen time cause PPS?
No direct link. Screens can worsen eye strain, but PPS is about choroid/RPE fluid dynamics.

9) Is PPS contagious or due to infection?
No. It’s not an infection.

10) Could both eyes be affected?
Yes, both eyes can show pachychoroid changes, and PPS may be bilateral. PMC

11) Is PPS hereditary?
There’s no clear hereditary pattern yet. Genetics are being studied in related conditions but remain unclear for PPS. Annual Reviews

12) How often should I follow up?
Your doctor will tailor this, but every 1–3 months early on is common until stable. OCT timing depends on your findings.

13) Can exercise or flying make it worse?
Regular moderate exercise is good for vascular health. Commercial flying is usually fine; ask your doctor if you have recent injections or complicated findings.

14) If I have OSA, will CPAP help my eyes?
CPAP treats OSA and may help reduce pachychoroid/CSC risk over time—good for overall health. Ajo

15) What’s the single most important thing I can do today?
Avoid steroids if medically possible, optimize sleep/OSA, reduce stress, and keep your follow-ups—and if distortion reaches the center, seek prompt care. ScienceDirectAjo

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 21, 2025.